Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-27 @ 11:37 AM
Study NCT ID:
NCT03567720
Status:
UNKNOWN
Last Update Posted:
2023-06-01
First Post:
2018-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Sponsor:
OncoSec Medical Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OMS-I141 (KEYNOTE-890)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |